Human Papillomavirus (HPV) is the most common DNA virus that causes infection in the epithelial cells of skin and mucosa. The moist epithelial surfaces (squamous cells) include all areas covered by skin and/or mucosae such as the mouth interior, throat, tongue, tonsils, vagina, cervix, vulva, penis (the urethra – the opening), and anus. Contact of the areas mentioned above with a virus leads to the transmission of the virus, allowing it to transfer between epithelial cells. While it is known that sexual contacts, both conventional and oral, are the means of transferring HPV through direct skin to skin contact, other possible pathways for the transfer of virus are still poorly known.
DelveInsight’s ‘Human Papillomavirus (HPV) Epidemiology Forecast to 2030‘ report delivers an in-depth understanding of the disease, historical and forecasted Human Papillomavirus (HPV) epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Geographies Covered
- The United States
- EU5 (Germany, France, Italy, Spain, and the United Kingdom)
- Japan
Study Period: 2017-2030
View report: https://www.delveinsight.com/sample-request/human-papillomavirus-hpv-epidemiology-forecast
Human Papillomavirus (HPV) Understanding
HPV can cause cervical and other cancers, including cancer of the vulva, vagina, penis, or anus. It can also cause cancer in the back of the throat, including the base of the tongue and tonsils (called oropharyngeal cancer). Cancer often takes years, even decades, to develop after a person gets HPV. Additionally, the types of HPV, which can cause genital warts, are not the same as the types of HPV that cause cancers.
The DelveInsight Human Papillomavirus (HPV) epidemiology report gives a thorough understanding of the Human Papillomavirus (HPV) by including details such as disease definition, symptoms, causes, pathophysiology, and diagnosis. It also provides treatment algorithms and treatment guidelines for Human Papillomavirus (HPV) in the US, Europe, and Japan. The report covers the detailed information of the Human Papillomavirus (HPV) epidemiology scenario in seven major countries (US, EU5, and Japan).
Human Papillomavirus (HPV) Epidemiology Perspective by DelveInsight
The Human Papillomavirus (HPV) epidemiology division provides insights about historical and current patient pool and forecasted trend for every seven major countries. The Human Papillomavirus (HPV) epidemiology data are studied through all possible division to give a better understanding of the Disease scenario in 7MM. The Human Papillomavirus (HPV) epidemiology segment covers the epidemiology data in the US, EU5 countries (Germany, Spain, Italy, France, and the UK), and Japan from 2017 to 2030. It also helps to recognize the causes of current and forecasted trends by exploring numerous studies, survey reports and views of key opinion leaders.
Request for sample pages: https://www.delveinsight.com/sample-request/human-papillomavirus-hpv-epidemiology-forecast
Scope of the Report
- The Human Papillomavirus (HPV) report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
- The Human Papillomavirus (HPV) Epidemiology Report and Model provide an overview of the risk factors and global trends of Human Papillomavirus (HPV) in the seven major markets (7MM:US, France, Germany, Italy, Spain, UK, and Japan)
- The report provides insight about the historical and forecasted patient pool of Human Papillomavirus (HPV) in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan
- The report helps to recognize the growth opportunities in the 7MM with respect to the patient population
- The report assesses the disease risk and burden and highlights the unmet needs of Human Papillomavirus (HPV)
- The report provides the segmentation of the Human Papillomavirus (HPV) epidemiology
Table of contents:
1. Key Insights
2. Executive Summary of Human Papillomavirus (HPV)
3. Human Papillomavirus (HPV): Disease Background and Overview
3.1. Introduction
3.2. Sign and Symptoms
3.3. Pathophysiology
3.4. Risk Factors
3.5. Diagnosis
4. Patient Journey
5. Epidemiology and Patient Population
5.1. Epidemiology Key Findings
5.2. Assumptions and Rationale: 7MM
5.3. Epidemiology Scenario: 7MM
5.3.1. Human Papillomavirus (HPV) Epidemiology Scenario in the 7MM (2017- 2030)
5.4. United States Epidemiology
5.4.1. Human Papillomavirus (HPV) Epidemiology Scenario in the United States (2017- 2030)
5.5. EU-5 Country-wise Epidemiology
5.5.1. Germany Epidemiology
5.5.1.1. Human Papillomavirus (HPV) Epidemiology Scenario in Germany (2017- 2030)
5.5.2. France Epidemiology
5.5.2.1. Human Papillomavirus (HPV) Epidemiology Scenario in France (2017- 2030)
5.5.3. Italy Epidemiology
5.5.3.1. Human Papillomavirus (HPV) Epidemiology Scenario in Italy (2017- 2030)
5.5.4. Spain Epidemiology
5.5.4.1. Human Papillomavirus (HPV) Epidemiology Scenario in Spain (2017- 2030)
5.5.5. United Kingdom Epidemiology
5.5.5.1. Human Papillomavirus (HPV) Epidemiology Scenario in the United Kingdom (2017-2030)
5.6. Japan Epidemiology
5.6.1. Human Papillomavirus (HPV) Epidemiology Scenario in Japan (2017- 2030)
6. Treatment Algorithm, Current Treatment, and Medical Practices
6.1. Human Papillomavirus (HPV) Treatment and Management
6.2. Human Papillomavirus (HPV) Treatment Algorithm
7. KOL Views
8. Unmet Needs
9. Appendix
9.1. Bibliography
9.2. Report Methodology
10. DelveInsight Capabilities
11. Disclaimer
12. About DelveInsight
*The table of contents is not exhaustive; will be provided in the final report
Download report: https://www.delveinsight.com/sample-request/human-papillomavirus-hpv-epidemiology-forecast
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end to end comprehensive solutions to improve their performance.
Contact us:
Shruti Thakur
info@delveinsight.com
+91965021333
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/